Occupational Medicine Advance Access published April 3, 2013
Occupational Medicine
doi:10.1093/occmed/kqt020
Case repOrt
Occupational asthma and rhinitis caused by
cyanoacrylate-based eyelash extension glues
I. Lindström1, H. Suojalehto1, M.-L. Henriks-Eckerman2 and K. Suuronen3
Control of Hypersensitivity Diseases, Finnish Institute of Occupational Health, Helsinki, Finland, 2Chemical Agents Team,
Finnish Institute of Occupational Health, Helsinki, Finland, 3Occupational Medicine Team, Finnish Institute of Occupational
Health, Helsinki, Finland.
1
Correspondence to: I. Lindström, Finnish Institute of Occupational Health, Topeliuksenkatu 41 a A, 00250 Helsinki, Finland.
Tel: +358 30 474 2136; fax: +358 30 474 2149; e-mail: irmeli.lindstrom@ttl.i
Aims
To report on a case of OA with OR and a case of OR attributable to lash extension glue and to evaluate respiratory exposure in lash extension work.
Methods
Two beauty professionals with suspected OA and/or OR underwent inhalation challenge, including
both control challenge and work-mimicking challenges using the lash extension glue, each with a
24-h follow-up. Volatile organic compounds (VOCs) present were assessed during the lash extension
glue challenge. The glues were analysed for their (meth)acrylate content.
Results
Both beauty professionals (case 1 and case 2) applied lash extensions regularly for several hours per
day as part of their work and had work-related rhinitis. Case 1 had a longer history of lash extension
work and also had asthmatic symptoms. The irst lash extension glue challenge was negative in both
cases, but positive OR reactions were detected in the second test. Case 1 also had a late asthmatic
reaction. During the lash extension glue challenge, VOC were present in total concentrations below
the irritant threshold and ethylcyanoacrylate (ECA) was detected in a concentration of 0.4 mg/m3.
Chemical analysis of the glues revealed ECA was the major component.
Conclusions Application of eyelash extensions using small amounts of cyanoacrylate-based glues can cause OA
and OR.
Key words
Asthma; cyanoacrylate; eyelash extension; glue; occupational; rhinitis; speciic inhalation challenge.
Introduction
Beauty professionals may handle chemicals that can
cause respiratory symptoms [1]. Little is known about
the sensitizing properties of these although the (meth)
acrylates used in artiicial nails [2,3] are recognized respiratory sensitizers.
In recent years, eyelash extensions have become
increasingly popular worldwide. According to a 2012 survey by the Finnish Laurea University of Applied Sciences,
about 2000 professionals regularly apply lash extensions
in Finland (population 5.4 million), and the market of
imported lash extension glues has approximately doubled
during the last 2 years (personal communication). Lash
extensions are attached to the customers’ lashes with
cyanoacrylate-based instant glues, in the worker’s breathing zone. Cyanoacrylate glues have caused occupational
asthma (OA) in industrial settings [4] and also in one nail
technician [3]. Recently, occupational allergic contact
dermatitis caused by lash extension glue was reported in
a lash beautician [5]. We report one case of OA and occupational rhinitis (OR) and one case of OR attributable to
lash extension glue containing ethylcyanoacrylate (ECA).
Case reports
Both beauty professionals had applied extensions
regularly to the eyelashes of several customers per day
using lash extension glue at 30–50 cm from their faces.
In case 1, symptoms appeared after 4 years, in case 2
© The Author 2013. Published by Oxford University Press on behalf of the Society of Occupational Medicine.
All rights reserved. For Permissions, please email: journals.permissions@oup.com
Downloaded from http://occmed.oxfordjournals.org/ at Tyoterveyslaitos on April 4, 2013
Background Eyelash extensions are applied on top of customers’ lashes using instant glue containing cyanoacrylate, known to cause occupational rhinitis (OR) and occupational asthma (OA). The number
of beauty professionals applying these extensions is increasing due to their popularity.
Page 2 of 4 OCCUPATIONAL MEDICINE
after four months. Case 1 also had occupational allergic
contact dermatitis caused by lash extension glue. Skin
prick tests did not show IgE-mediated sensitization to
lash extension glue.
Inhalation challenge took place in a 6-m3 challenge
chamber on subsequent days, each with a 24-h followup. In the control challenge 2 ml of a control solution was
sprayed into the chamber, in which the patient stayed for
15 min. Both patients underwent the lash extension glue
challenge twice. In case 1, ive drops of the glue were
dripped into a beaker on a warm plate (35ºC) three times
(at 0, 15 and 30 min; total 15 drops), after which the
patient stayed in the chamber for another 15 min. In case
2, the challenge was performed in the same way, but with
three drops of glue dripped up to four times at 15-min
intervals.
Table 1. Characteristics of patient cases, measurements during lash extension glue challenge and chemical analysis of the glues
Measurements and chemical analysis
VOC during inhalation challenge (mg/m3)
Chemical analysis of LEG
Case 2
37
Female
Ex-smoker
<1
No
22
Female
Current smoker
<1
No
6
3–9 h
4 years
Paper mask occasionally
No
Twice
Yes
1
4h
4 months
Paper mask occasionally
No
About 20 times
No
Rhinitis, dyspnoea
Dermographismus
Inhaled luticasone 500 µg/day
No
2.97/83
70.82/85
34.2
Suggestive worsening at work
Rhinitis
Negative (0 mm)
None
No
3.38/90
94.40/106
11.9
Not measured
−26% (late)
No
+25.8
Positive (920 mg)
Occupational asthma
Occupational rhinitis
Contact dermatitisd
−6%
Not measured
Not measured
Positive (2120 mg)
Occupational rhinitis
Not measured
Glue 1
ECA: >95%e
MMA: 0.072%
BA: 0.014%
Glue 2
ECA: >95%e
MMA: 0.031%
BA: 0.012%
TVOC: 0.48 ECA: 0.4
ECA: >95%e
MMA: 0.013%
LEG, lash extension glue; SPT, skin prick test; FEV1, forced expiratory volume in 1 second; FVC, forced ventilation capacity; FENO, fractional exhaled nitric oxide;
ppb, parts per billion; PEF, peak expiratory low; TVOC, total concentration of volatile organic compounds; MMA, methylmethacrylate; BA, butylacrylate.
a
SPTs were performed with LEG as such.
b
In bronchial challenge with histamine.
c
In both cases, reactions were detected in the 2nd challenges to LEG. In Case 1, luticasone was ongoing during the challenges.
d
An earlier diagnosis of allergic contact dermatitis (caused by ethylcyanoacrylate and paraphenylenediamine).
e
Purity according to GC–MS analysis.
Downloaded from http://occmed.oxfordjournals.org/ at Tyoterveyslaitos on April 4, 2013
Demographics
Age
Gender
Smoking
Pack-years
Atopy
Exposure
Exposure to LEG, years
Duration of application task/day
Duration of exposure before symptoms
Respiratory protection
Use of protective gloves
Lash extensions applied to the patient herself
Exposure to methacrylates of artiicial nails
Clinical details
Respiratory symptoms related to LEG
SPT to LEGa
Medication for asthma and rhinitis
Bronchial hyperresponsivenessb
FEV1, litres/% of predicted
FEV1/FVC, absolute/% of predicted
FENO, ppb
Serial PEF monitoring at work and on days off
Speciic inhalation challenge reactionc
FEV1 decrease
Change in bronchial hyperresponsivenessb
Change in FENO, ppb
Nasal (amount of secretion)
Diagnosis
Case 1
I. LINDSTRöM ET AL.: OA AND OR CAUSED BY CYANOACRYLATE-BASED EYELASH ExTENSION GLUES Page 3 of 4
tert-butylmethylether. ECA was found to be the major
component of the glues.
Table 1 describes the two cases, the results of air
measurements and of chemical analysis of the glues.
Figure 1 shows the SIC reaction in case 1. Both patients
gave their written consent to testing and publishing.
Discussion
To our knowledge, this is the irst report of OA and OR
attributable to lash extension glue veriied using a SIC,
including a control challenge.
Cyanoacrylates such as ECA bond with even the most
dissimilar materials quickly and irmly and consequently
are used in instant glues for industrial and household purposes and in wound adhesives in health care. In addition
to ECA, which has low volatility, small amounts of other
alkyl-cyanoacrylates or (meth)acrylic derivatives may be
present. Chemical analysis of the glues also revealed small
amounts of methylmethacrylate and/or butylacrylate that,
unlike ECA, evaporate quite easily. Nevertheless, the total
amount of airborne (meth)acrylate derivatives is likely to
be below the irritant threshold during the application of
lash extensions. In the lash extension glue challenge in
case 2, VOCs were found in the air, but their concentration was clearly below typical industrial levels and below
the recommended limit for Finnish houses and ofices
(0.6 mg/m3). Individual components such as ECA were
present in concentrations unlikely to cause airway irritation although ECA seems to have evaporated quite effectively considering its poor volatility and the small amount
of glue applied. This supports the hypothesis that the reactions result from sensitization rather than from irritation.
Figure 1. SIC of case 1, illustrating the changes in FEV1. The control challenge involved nebulizing 2 ml of the control diluent (solution of 0.5%
NaCl, 0.4% phenol and 0.3% NaHCO3 in sterile water) into the chamber by pressured air. The lash extension glue challenge lasted 45 min and
was carried out twice with the patient’s own glue. A late reaction was seen in the second challenge with the lash extension glue. *Bronchodilator
medication; **Prednisolone.
Downloaded from http://occmed.oxfordjournals.org/ at Tyoterveyslaitos on April 4, 2013
The speciic inhalation challenge (SIC) was considered positive for OA if forced expiratory volume in 1 s fell
by ≥20% of the pre-challenge value in the glue challenge,
without signiicant changes in the control challenge [6]. We
evaluated the degree of rhinorrhea and nasal blockage using
anterior rhinoscopy and scored them, both 20 min before
and 20 min after the challenge [7]. A signiicant score
change without signiicant changes following the control
challenge was considered a positive OR reaction. We also
measured the amount of nasal secretion running out of the
patient’s nose to the vestibulum of the nostrils. An amount
more than 200 mg supported a positive test reaction.
In both cases, the irst glue challenge was negative.
The fact that case 1 used inhaled corticosteroids during
SIC and had stopped lash extension work 9 months previously may have affected the outcome of this challenge.
Moreover, earlier studies have shown that repeated challenges may be needed to conirm diagnosis [8]. Positive
rhinitis reactions occurred in the second test, and case 1
had a prolonged late asthma reaction with an increase in
fractional exhaled nitric oxide level, conirming the diagnosis of OA. This type of reaction caused by cyanoacrylate-based glues has been described before [4].
We assessed the volatile organic compound (VOC)
concentration during case 1’s SIC through Tenax sorbent tube collection and gas chromatography–mass spectrometry (GC–MS) analysis [9]. VOC concentrations
were below the irritant level during the lash extension
glue challenge, ECA concentration was about 40%
of its Finnish occupational exposure limit, 1 mg/m3,
and no other (meth)acrylates were detected. We analysed the beauty professionals’ glues for their (meth)
acrylate contents using GC–MS after extraction using
Page 4 of 4 OCCUPATIONAL MEDICINE
Key points
•
•
•
Eyelash extension glues for professional use are
usually based on cyanoacrylates.
Applying eyelash extensions may release cyanoacrylates into the air.
Lash extension glues may cause occupational
asthma and rhinitis.
Acknowledgements
Henna Ylilauri from the Laurea University of Applied
Sciences is kindly acknowledged for the lash extension market survey.
Conlicts of interest
None declared.
References
1. Tsigonia A, Lagoudi A, Chandrinou S, Linos A, Evlogias
N, Alexopoulos EC. Indoor air in beauty salons and
occupational health exposure of cosmetologists to
chemical substances. Int J Environ Res Public Health
2010;7:314–324.
2. Sauni R, Kauppi P, Alanko K, Henriks-Eckerman ML,
Tuppurainen M, Hannu T. Occupational asthma caused by
sculptured nails containing methacrylates. Am J Ind Med
2008;51:968–974.
3. Jurado-Palomo J, Caballero T, Fernández-Nieto M,
Quirce S. Occupational asthma caused by artiicial
cyanoacrylate ingernails. Ann Allergy Asthma Immunol
2009;102:440–441.
4. Quirce S, Baeza ML, Tornero P, Blasco A, Barranco R,
Sastre J. Occupational asthma caused by exposure to
cyanoacrylate. Allergy 2001;56:446–449.
5. Pesonen M, Kuuliala O, Henriks-Eckerman ML,
Aalto-Korte K. Occupational allergic contact dermatitis caused by eyelash extension glues. Contact Derm
2012;67:307–308.
6. Vandenplas O, Malo JL. Inhalation challenges with
agents causing occupational asthma. Eur Respir J
1997;10:2612–2629.
7. Hytönen M, Sala E. Nasal provocation test in the diagnostics of occupational allergic rhinitis. Rhinology
1996;34:86–90.
8. Lemière C, Cartier A, Dolovich J et al. Outcome of speciic bronchial responsiveness to occupational agents
after removal from exposure. Am J Respir Crit Care Med
1996;154:329–333.
9. Indoor Air—Part 6: Determination of Volatile Organic
Compounds In Indoor and Test Chamber Air by Active
Sampling on Tenax TA Sorbent, Thermal Desorption and Gas
Chromatography Using MS/FID. Geneva: International
Organization for Standardization (ISO), 2004.
10. Kreiss K, Esfahani RS, Antao VC, Odencrantz J, Lezotte
DC, Hoffman RE. Risk factors for asthma among cosmetology professionals in Colorado. J Occup Environ Med
2006;48:1062–1069.
Downloaded from http://occmed.oxfordjournals.org/ at Tyoterveyslaitos on April 4, 2013
In Finland, the rapid growth of the lash extension market in recent years makes the number of exposed workers dificult to estimate. Our cases applied lash extensions
part time, but the number who work exclusively applying
lash extensions seems to be increasing. In another activity with (meth)acrylate exposure, artiicial nail application, Kreiss et al. reported an almost 3-fold-increased risk
of asthma among beauticians [10]. This risk may also be
increased in lash extension work although respiratory
exposure is likely to be lower than in nail application.
Our results indicate glues containing cyanoacrylates
may cause OA and OR in workers applying lash extensions. Cyanoacrylate glues are unlikely to be substituted
by other glues in the near future because of their technical properties. The use of effective respiratory protective
equipment in lash extension work would be beneicial,
but it is likely to be poorly accepted. Additionally, effective local exhaust ventilation is not practical as the lashes
may be caught by the airlow. Thus to prevent OR and OA
salons offering lash extensions should provide effective
general ventilation. Workers with symptoms should be
evaluated fully and may need to change their work tasks.